Earth Science Tech, Inc. (OTC: ETST) has officially launched its MyOnlineConsultation.com telehealth platform through MOCTeledoc LLC following a successful beta phase that achieved cash-flow-positive status. The platform represents a strategic expansion of the company's vertically integrated healthcare ecosystem, connecting its prescriber network with compounding pharmacies while positioning MOCTeledoc as a new revenue stream alongside divisions that generated $25.9 million for the nine months ended Dec. 31, 2025.
The importance of this launch lies in its demonstration of how healthcare companies are increasingly building comprehensive digital ecosystems rather than offering isolated services. By integrating telehealth technology, clinical staffing, and medication fulfillment through partnerships with compounding pharmacies like RxCompound and Mister Meds, Earth Science Tech creates a seamless patient experience that could improve access to specialized medications and consultations. This approach addresses growing consumer demand for integrated healthcare solutions that reduce fragmentation in treatment.
For the healthcare industry, the platform's cash-flow-positive status following its beta phase suggests a viable business model in the competitive telehealth sector. The integration with compounding pharmacies is particularly significant, as it connects patients needing customized medications directly with prescribers and specialized pharmacies. This vertical integration model could potentially reduce costs and improve medication adherence by streamlining what has traditionally been a complex process involving multiple providers.
The platform's launch through MOCTeledoc, which provides technology and clinical staffing solutions to digital health companies, positions Earth Science Tech to potentially serve other telehealth providers while expanding its own patient base. This dual approach—serving both end patients and other healthcare companies—could create multiple revenue streams and increase the company's market reach. The company's existing healthcare operations include RxCompoundStore.com and Mister Meds, two licensed compounding pharmacies operating across multiple U.S. states.
For investors and industry observers, the $25.9 million generated by other divisions in the nine-month period ending December 31, 2025, provides context for understanding the potential scale of this new platform. The full details of the launch are available in the company's press release at https://ibn.fm/Pang9. Earth Science Tech operates as a diversified holding company focused on health and wellness through multiple subsidiaries, including telemedicine platforms, compounding pharmacies, and healthcare facilities, supported by additional business units in real estate and consumer products.
The broader implications of this launch extend to how healthcare delivery continues to evolve post-pandemic, with telehealth becoming increasingly integrated with specialized pharmacy services. As patients seek more convenient access to customized treatments, platforms that combine consultation, prescription, and fulfillment could set new standards for patient care. The success of this integrated model could influence how other healthcare companies structure their digital offerings in an increasingly competitive market.
